MediPharm Labs (LABS) Competitors C$0.09 -0.01 (-5.26%) As of 04/4/2025 03:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. RX, CRDL, HLS, TGOD, NINE, SUGR, WMD, MDP, HEXO, and VIRShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include BioSyent (RX), Cardiol Therapeutics (CRDL), HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), SugarBud Craft Growers (SUGR), WeedMD (WMD), Medexus Pharmaceuticals (MDP), HEXO (HEXO), and Viridium Pacific Group (VIR). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. BioSyent Cardiol Therapeutics HLS Therapeutics Green Organic Dutchman Delta 9 Cannabis SugarBud Craft Growers WeedMD Medexus Pharmaceuticals HEXO Viridium Pacific Group BioSyent (CVE:RX) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Do institutionals & insiders hold more shares of RX or LABS? 1.4% of BioSyent shares are owned by institutional investors. Comparatively, 0.7% of MediPharm Labs shares are owned by institutional investors. 33.7% of BioSyent shares are owned by company insiders. Comparatively, 4.5% of MediPharm Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk & volatility, RX or LABS? BioSyent has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Does the media prefer RX or LABS? In the previous week, BioSyent had 1 more articles in the media than MediPharm Labs. MarketBeat recorded 2 mentions for BioSyent and 1 mentions for MediPharm Labs. BioSyent's average media sentiment score of 0.71 beat MediPharm Labs' score of 0.00 indicating that BioSyent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioSyent 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MediPharm Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation & earnings, RX or LABS? BioSyent has higher earnings, but lower revenue than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than BioSyent, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioSyentC$34.06M3.32C$7.02MC$0.6216.07MediPharm LabsC$39.42M0.95-C$12.05M-C$0.03-3.10 Is RX or LABS more profitable? BioSyent has a net margin of 20.60% compared to MediPharm Labs' net margin of -30.56%. BioSyent's return on equity of 20.01% beat MediPharm Labs' return on equity.Company Net Margins Return on Equity Return on Assets BioSyent20.60% 20.01% 12.86% MediPharm Labs -30.56%-24.41%-7.17% Does the MarketBeat Community believe in RX or LABS? BioSyent received 69 more outperform votes than MediPharm Labs when rated by MarketBeat users. Likewise, 66.20% of users gave BioSyent an outperform vote while only 65.79% of users gave MediPharm Labs an outperform vote. CompanyUnderperformOutperformBioSyentOutperform Votes9466.20% Underperform Votes4833.80% MediPharm LabsOutperform Votes2565.79% Underperform Votes1334.21% SummaryBioSyent beats MediPharm Labs on 14 of the 15 factors compared between the two stocks. Remove Ads Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$37.35MC$2.18BC$5.26BC$5.31BDividend YieldN/A2.92%4.89%6.44%P/E Ratio-3.104.3021.3829.37Price / Sales0.95513.86355.32519.28Price / Cash1.3010.2538.1883.35Price / Book0.826.236.233.28Net Income-C$12.05MC$20.70BC$3.21BC$300.83M7 Day PerformanceN/A-3.98%-8.47%-7.30%1 Month PerformanceN/A-6.15%-4.87%-6.72%1 Year PerformanceN/A81.91%2.54%4.24% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.09-5.3%N/A+5.9%C$37.35MC$39.42M-3.10130RXBioSyentN/AC$11.15-1.8%N/A+14.5%C$127.53MC$34.06M18.10N/ANews CoveragePositive NewsCRDLCardiol TherapeuticsN/AC$1.37-0.7%N/A-56.6%C$113.68MN/A-2.6920News CoverageGap DownHLSHLS Therapeutics0.3804 of 5 starsC$4.65-0.2%C$4.50-3.2%-0.7%C$103.45MC$40.13M-4.6691TGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940News CoverageGap UpSUGRSugarBud Craft GrowersN/AC$12.00flatN/A+9,900.0%C$81.84MC$575.64M14.4644Gap DownHigh Trading VolumeWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpMDPMedexus Pharmaceuticals2.2166 of 5 starsC$2.42+0.8%C$5.49+126.8%+31.9%C$54.18MC$100.25M11.5798HEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up Remove Ads Related Companies and Tools Related Companies BioSyent Competitors Cardiol Therapeutics Competitors HLS Therapeutics Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors SugarBud Craft Growers Competitors WeedMD Competitors Medexus Pharmaceuticals Competitors HEXO Competitors Viridium Pacific Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LABS Stock Free LABS Stock Alerts